HRX215
Product Specifications
CAS Number
2369583-33-3
Synonyms
Darizmetinib
SKU
C01965-5mg
Target
P38 MAPK
Applications
MAPK
Additionnal Information
HRX215 (Darizmetinib) is a first-in-class, highly potent, selective, and orally active inhibitor of MKK4 with an IC50 of 0.02 μM. It enhances liver regeneration, prevents liver failure following extensive hepatectomy in pigs, and has potential to prevent liver failure after major oncological liver resections or transplantation of small liver grafts in humans.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1093845-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis Putative HTH-type transcriptional regulator ywnA (ywnA)
Ask
View Details MBS1093845-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis Putative HTH-type transcriptional regulator ywnA (ywnA)
Ask
View Details MBS1093845-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis Putative HTH-type transcriptional regulator ywnA (ywnA)
Ask
View Details MBS1093845-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis Putative HTH-type transcriptional regulator ywnA (ywnA)
Ask
View Details MBS1093845-05 0.02 mg (Baculovirus)
Recombinant Bacillus subtilis Putative HTH-type transcriptional regulator ywnA (ywnA)
Ask
View Details